Ibm Retirement Fund Seagen Inc. Transaction History

Ibm Retirement Fund

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 20, 2022	SELL	$108.81 - $179.33 $231,438 - $381,434	-2,127 Closed	0 $0
Q1 2022 Apr 14, 2022	SELL	$119.61 - $157.85 $11,243 - $14,837	-94 Reduced 4.23%	2,127 $306,000
Q4 2021 Jan 19, 2022	SELL	$142.57 - $190.86 $220,270 - $294,878	-1,545 Reduced 41.02%	2,221 $343,000
Q2 2021 Jul 12, 2021	SELL	$135.08 - $161.1 $75,644 - $90,216	-560 Reduced 12.94%	3,766 $595,000
Q1 2021 Apr 22, 2021	SELL	$137.51 - $190.8 $29,839 - $41,403	-217 Reduced 4.78%	4,326 $601,000
Q4 2020 Jan 25, 2021	BUY	$164.63 - $211.93 $747,914 - $962,797	4,543 New	4,543 $796,000

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Ibm Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on Ibm Retirement Fund with notifications on news.